Provision of subsidized malaria drugs in shops improves uptake

Reporting the findings of a cluster randomized trial carried out in rural Kenya, Beth Kangwana and colleagues find that provision of packs of the malaria therapy artemether-lumefantrine in shops at a subsidized price more than doubled the proportion of children with fever who received drugs promptly.

Importantly, whilst enabling cheap and easy purchase of in shops enabled treatment of about 44% of children with fever, this is still much lower than the target of treating 80% of children with fever set by the Roll Back Malaria Partnership.

So in addition to this type of pragmatic solution to the problem of access to drugs, additional strategies will be required to boost the numbers of children with who are treated with antimalarials.

More information: Kangwana BP, Kedenge SV, Noor AM, Alegana VA, Nyandigisi AJ, et al. (2011) The Impact of Retail-Sector Delivery of Artemether–Lumefantrine on Malaria Treatment of Children under Five in Kenya: A Cluster Randomized Controlled Trial. PLoS Med 8(5): e1000437. doi:10.1371/journal.pmed.1000437

Citation: Provision of subsidized malaria drugs in shops improves uptake (2011, June 1) retrieved 18 April 2024 from https://medicalxpress.com/news/2011-06-provision-subsidized-malaria-drugs-uptake.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

The majority of fevers in African children are not caused by malaria

 shares

Feedback to editors